Interleukin-6–dependent survival of multiple myeloma cells involves the Stat3-mediated induction of microRNA-21 through a highly conserved enhancer

Dennis Löffler(Leipzig University), Katja Brocke-Heidrich(Leipzig University), Gabriele Pfeifer(Leipzig University), Claudia Stocsits(Leipzig University), Jörg Hackermüller(Fraunhofer Institute for Cell Therapy and Immunology), A. Kretzschmar(Fraunhofer Institute for Cell Therapy and Immunology), Renate Burger(University Hospital Schleswig-Holstein), Martin Gramatzki(University Hospital Schleswig-Holstein), Conny Blumert(Leipzig University), Kay Bauer(Leipzig University), Helena Cvijic(Leipzig University), A. Kerstin Ullmann(Leipzig University), Peter F. Stadler(Fraunhofer Institute for Cell Therapy and Immunology), Friedemann Horn(Fraunhofer Institute for Cell Therapy and Immunology)
Cited by 635Open Access
Full Text

Abstract

Signal transducer and activator of transcription 3 (Stat3) is implicated in the pathogenesis of many malignancies and essential for IL-6-dependent survival and growth of multiple myeloma cells. Here, we demonstrate that the gene encoding oncogenic microRNA-21 (miR-21) is controlled by an upstream enhancer containing 2 Stat3 binding sites strictly conserved since the first observed evolutionary appearance of miR-21 and Stat3. MiR-21 induction by IL-6 was strictly Stat3 dependent. Ectopically raising miR-21 expression in myeloma cells in the absence of IL-6 significantly reduced their apoptosis levels. These data provide strong evidence that miR-21 induction contributes to the oncogenic potential of Stat3.


Related Papers

No related papers found

Powered by citation graph analysis